Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: The reappraisal of positive lymph node ratio as a proper N-staging

Annals of Surgery

Volumn 255, Issue 1, 2012, Pages 50-58

  Kong, Seong Ho ^a   Lee, Hyuk Joon ^a   Ahn, Hye Seong ^a   Kim, Jong Won ^a   Kim, Woo Ho ^a   Lee, Kuhn Uk ^a   Yang, Han Kwang ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; DISEASE PROGRESSION; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84055199646     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31821d4d75     Document Type: Article

References (36)

1. JGCS. Guidelines for diagnosis and treatment of carcinoma of the stomach, 2nd English Edition, 2004. Available at: http://www.jgca.jp. Accessed February 1, 2010.
2. Smith D, Schwarz R, Schwarz R. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large USpopulation database. J Clin Oncol. 2005;23:7114-7124.
3. Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss; 2002.
4. Moon HG, Han W, Noh DY. Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean Breast Cancer Society. J Clin Oncol. 2010;28:1692-1699.
5. Weir L, Speers C, D'Yachkova Y, et al. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol. 2002;20:1793-1799. (Pubitemid 34273268)
6. Polednak AP. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg. 2003;237:163-167. (Pubitemid 38173241)
7. Le Voyer T, Sigurdson E, Hanlon A, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912.
8. Chang G, Rodriguez-Bigas M, Skibber J, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433.
9. Siewert J, Bottcher K, Roder J, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg. 1993;80:1015-1018. (Pubitemid 23261584)
10. Wu CW, Hsiung CA, Lo SS, et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006;7:309-315.
11. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D 1 and D 2 resections for gastric cancer: long-termresults of theMRCrandomized surgical trial. Br J Cancer. 1999;79:1522.
12. Bonenkamp J, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340:908.
13. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608. (Pubitemid 15062653)
14. Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol. 2005;12:981-987. (Pubitemid 41660673)
15. Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143-2151. (Pubitemid 44665647)
16. Mullaney PJ, Wadley MS, Hyde C, et al. Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer. Br J Surg. 2002;89:1405-1408.
17. Kulig J, Sierzega M, Kolodziejczyk P, et al. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg. 2009;96:910-918.
18. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245:543-552. (Pubitemid 46555657)
19. Cheong JH, Hyung WJ, Shen JG, et al. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol. 2006;13:377-385.
20. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27-34. (Pubitemid 34262894)
21. Katai H, Yoshimura K, Maruyama K, et al. Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer. 2000;88:1796-1800. (Pubitemid 30212987)
22. Sobin LH, M.K. G, Wittekind C, TNM Classification of Malignant Tumors. 7th ed. Chichester, UK: Blackwell Publishing Ltd; 2009.
23. Roder JD, Bottcher K, Busch R, et al. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer. 1998;82:621-631. (Pubitemid 28090271)
24. Wagner PK, Ramaswamy A, Ruschoff J, et al. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg. 1991;78:825-827.
25. Kong SH, Kim JW, Lee HJ, et al. The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy. Ann Surg Oncol. 2009;16:3252-3258.
26. Bouvier AM, Haas O, Piard F, et al. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862-2866. (Pubitemid 34547684)
27. Kunisaki C, Shimada H, Nomura M, et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res. 2005;25:1369-1375. (Pubitemid 40546817)
28. Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326.
29. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784.
30. Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for Ncategories in the TNM Classification? Tumor Node Metastasis. J Surg Oncol. 1998;69:15-20. (Pubitemid 28452268)
31. Kim C, Yang D. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol. 2009;16:1868-1874.
32. Liu C, Lu P, Lu Y, et al. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer. 2007;7:200.
33. Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59-66. (Pubitemid 40103926)
34. Bunt AM, Hermans J, Smit VT, et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol. 1995;13:19-25.
35. Wang X, Wan F, Wang J. A common misuse of stepwise regression in studies of ratio of metastatic lymph nodes for gastric cancer. Ann Surg Oncol. 2008;15:1805-1806.
36. Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165.